Remap Consulting is a specialist pharmaceutical pricing and market access consultancy
We work with people responsible for the pricing and reimbursement of products who are asking:
What is the optimal price for our product?
Have we got the right evidence to support pricing and market access at launch?
Do we have the right training capabilities in house to secure pricing and reimbursement?
What is the pricing and market access potential for our business development opportunities?
Launch
Implementation
Price & Market Access Training
Price
Optimization
We now offer the NICE META tool as part of our Launch service
Our mission is to support you in solving your pricing and market access challenges to improve patient access to your products
This has been an excellent two days. You have truly been a pleasure to work with, bringing great learning techniques as well as pricing and market access insights.
Excellent work. The project ran very smoothly and we appreciated your efficient approach to managing the project and delivery of final recommendations.
Latest News
Charlie is attending the Westminster Health Forum Keynote Seminar tomorrow
The topic is 'Biosimilars in the NHS - commissioning, development and engagement with clinicians and patients'. If you are in [...]
One lung cancer drug receives NHS England approval, while another is rejected
Article courtesy of Cancer Research UK. A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision drug, for the [...]
Joint pricing and health technology assessment between European countries: is this the future of pricing and market access negotiations?
Since 2015 there has been substantial growth in the number of multi-country collaborations across Europe, driven primarily by the increasing [...]